Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Conditions
- Chronic Myeloproliferative Disorders
- Graft Versus Host Disease
- Leukemia
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases
Interventions
- BIOLOGICAL: anti-thymocyte globulin
- DRUG: busulfan
- DRUG: cyclophosphamide
- DRUG: cyclosporine
- DRUG: methotrexate
- PROCEDURE: allogeneic bone marrow transplantation
- PROCEDURE: peripheral blood stem cell transplantation
Sponsor
Fred Hutchinson Cancer Center
Collaborators